... 帕唑帕尼 Pazopanib (Votrient) 聚乙二醇干扰素 PEG Interferon 喷司他丁 Pentostatin (Nipent) ...
基于1个网页-相关网页
PEG-interferon 聚乙二醇干扰素
Methods 33 patients were randomly divided into 2 groups and treated with Peginterferon alfa-2a (16 patients) and Entecavir (17 patients) for 48 weeks respectively.
方法:采用随机、开放、对照的方法,33例ALT<2ULN肝组织学炎症≥G2的HBeAg阴性慢性乙肝分为聚乙二醇干扰素ɑ-2a组16例和恩替卡韦对照组17例,分别接受48周的治疗。
参考来源 - 聚乙二醇干扰素ɑ·2,447,543篇论文数据,部分数据来源于NoteExpress
I am currently taking PEG Interferon for Hep B but it's just something that my Doctor is doing and it is not officially approved for Hep B.
我的医生给我用的PEG-干扰素目前还没有被通过作为治疗乙肝的药物。
This will comprise of direct antiviral drugs such as protease inhibitors along with peg-Interferon and ribavirin. This can provide a sustained virological response in over 70% of patients.
应用三联疗法的患者中,超过70%的患者能够达到持续病毒学应答,同时对难治性基因型患者也能获得很好的疗效。
It establishes theoretic foundation for the prediction of efficacy of PEG-interferon, and provides theoretic knowledge for the rational therapy of patients with chronic viral hepatitis b.
对开展聚乙二醇干扰素疗效预测奠定基础,为慢性乙型肝炎的合理治疗提供理论依据。
应用推荐